|
|
|
Insider
Information: |
Zarrabian Saiid |
Relationship: |
Head of Strategic Part... |
City: |
Patterson |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
164,731 |
|
Indirect Shares
|
1,278 |
|
|
Direct
Value |
$684,084 |
|
|
Indirect Value
|
$4,329 |
|
|
Total
Shares |
166,009 |
|
|
Total
Value |
$688,413 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Penwest Pharmaceuticals Co |
PPCO |
Director |
2010-09-20 |
0 |
2010-06-30 |
0 |
Premium* |
|
La Jolla Pharmaceutical Co |
LJPC |
Director |
2015-05-14 |
109,231 |
2015-05-14 |
688 |
Premium* |
|
Kintara Therapeutics, Inc |
KTRA |
Head of Strategic Part... |
2021-12-07 |
55,500 |
2021-12-07 |
590 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PPCO |
Penwest Pharmaceuticals C... |
Director |
|
2010-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
Director |
|
2010-09-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,000) |
0 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Director |
|
2012-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
11,541,334 |
11,541,334 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Director |
|
2013-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
1,480,442 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Director |
|
2013-09-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,360,892) |
1,480,442 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Director |
|
2013-09-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,981,146 |
5,461,588 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Director |
|
2014-07-31 |
4 |
B |
$9.53 |
$3,631 |
I/I |
381 |
381 |
2.1 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Director |
|
2015-05-14 |
4 |
B |
$19.50 |
$5,987 |
I/I |
307 |
688 |
2.1 |
- |
|
KTRA |
Kintara Therapeutics, Inc |
Interim CEO |
|
2017-11-14 |
4 |
B |
$0.82 |
$45,100 |
D/D |
55,000 |
55,000 |
2.81 |
- |
|
KTRA |
Kintara Therapeutics, Inc |
Interim CEO |
|
2017-11-14 |
4 |
B |
$0.84 |
$4,956 |
I/I |
5,900 |
5,900 |
2.58 |
- |
|
KTRA |
Kintara Therapeutics, Inc |
Head of Strategic Partnerships |
|
2021-12-06 |
4 |
B |
$0.59 |
$7,018 |
D/D |
11,891 |
17,391 |
2.81 |
- |
|
KTRA |
Kintara Therapeutics, Inc |
Head of Strategic Partnerships |
|
2021-12-07 |
4 |
B |
$0.64 |
$24,298 |
D/D |
38,109 |
55,500 |
2.81 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|